Ignite Creation Date:
2024-05-06 @ 7:58 PM
Last Modification Date:
2024-10-26 @ 3:18 PM
Study NCT ID:
NCT06205589
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-03
First Post:
2024-01-04
Brief Title:
Therapeutic ID93 GLA-SE Vaccination in Participants With Rifampicin-Susceptible Pulmonary TB
Sponsor:
Organization:
Advancing Clinical Therapeutics Globally for HIVAIDS and Other Infections